Details

NameSymbolSector
ANG LIFESCIENCES INDIA LIMITEDANGPharmaceuticals
Open
34.77
High
35.1
Low
34.77
Close
35.1
Volume
3733
Exchange
bse
Time
08-Sep-2026

Outlook

Score:

3

Rating:

RISKY

Candlestick Pattern

CandlepatternofAngLifesciencesIndiais
Marubozu
EstimatedStoplossofAngLifesciencesIndiais
34.77
AngLifesciencesIndiahasa
Bullishℹ
pattern.
Formationof
Marubozu
candlepatternindicatesAngLifesciencesIndiahaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

AngLifesciencesIndiaisin
Sideways trendℹ
.
PriceofAngLifesciencesIndiais
Upℹ
by

6.36

%.
Target
Buy@

25.8

Sell@

39.62

Current@

35.1

Volume

ThetradevolumesofAngLifesciencesIndiahavebecome
Deficientℹ
ThoughthevolumetrendforAngLifesciencesIndiaappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofAngLifesciencesIndiais

Down

by

65.27

%

Valuation

ThecurrentmarketpriceofAngLifesciencesIndiais
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth229crandtotalassetsworth229cr,thebalancesheetofAngLifesciencesIndiais:
Balancedℹ
.
Cashflow
AngLifesciencesIndiahas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
0% in operatingℹ
50% i.e. ₹ 1cr spent in investingℹ
50% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
AngLifesciencesIndiahas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
23.68% i.e. ₹ 9cr spent in operatingℹ
50% i.e. ₹ 19cr earned in investingℹ
26.32% i.e. ₹ 10cr spent in financingℹ
0% in otherℹ
Income
TheincomeofAngLifesciencesIndiais

₹ 26cr

and

Loss

is:

₹ 2cr

AngLifesciencesIndiaLossesincreasedby:

0

%andIncomeisUpby:

8.33

%
TheincomeofAngLifesciencesIndiais

₹ 24cr

and

Loss

is:

₹ 2cr

AngLifesciencesIndiaLossesincreasedby:

0

%andIncomeisUpby:

41.18

%
TheincomeofAngLifesciencesIndiais

₹ 17cr

and

Loss

is:

₹ 2cr

AngLifesciencesIndiaLossesdecreasedby:

60

%andIncomeisDownby:

29.17

%
By using this site you agree to the use of cookies to deliver a better site experience.